More PRNewswire
View Older Stories View Newer Stories-
Leoguar Rolls Out Sprint Utility Ebike at $999: Combining Fat Tire Stability with a Universal 3-in-1 Rear Mount for Urban Life
-
BorgWarner Secures New High Voltage Coolant Heater Programs in China, Korea and Japan
-
Introducing a New Public Art Installation in San Francisco's Union Square, "Madame Theodore's Floral Academy for Wayward Travelers"
-
Western National Parks Association Launches New Online Store
-
Dovetail Genomics Showcases LinkPrep™ Technology Performance in Multiple Myeloma at ASHG
-
KORE to Report Third Quarter 2024 Results on November 13, 2024
-
Kellanova Reports 2024 Third Quarter Results
-
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
-
GRAINGER REPORTS RESULTS FOR THE THIRD QUARTER 2024
-
REPORT HIGHLIGHTS OPPORTUNITIES AND RISKS TO FINANCIAL INCLUSION AS FINANCIAL SECTOR RESPONDS TO ESCALATING FRAUD AND SCAM ACTIVITY
-
Roundhill Investments Launches S&P 500® Target 20 Managed Distribution ETF (XPAY)
-
Arrow Reports 3rd Quarter Net Income of $9.0 Million, or $0.53 per Share
-
Oasis Security Launches Industry-First Non-Human Identity Ownership Discovery Engine
-
DDB Named One of America's Most Reliable Companies by Newsweek
-
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology
-
BorgWarner Extends Transfer Case Business with North American OEM
-
BGC Reports Third Quarter 2024 Financial Results
-
Fertilitywise Announces Partnership with Fertility and Surrogacy Legal Group
-
Cango Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 Eastern Time
-
Evommune Announces $115 Million Series C Financing to Accelerate Advancement of Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases
-
Drilling Tools International Corp. Signs Definitive Agreement to Acquire UK-Based Titan Tools Services Ltd., Expanding its Global Reach in Downhole Tool Services
-
NexPhase Capital Named to Inc.'s 2024 List of Founder-Friendly Investors for Fourth Consecutive Year
-
Plandek Positioned as the Leader in the 2024 SPARK Matrix™ for Software Engineering Intelligence Platform by QKS Group
-
FluoSphera Expands Its Systemic Technology Platform to empower ADCs to meet their promise
-
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
-
Sabre's third quarter 2024 earnings materials available on its Investor Relations website
-
Axon Ivy is Positioned as the Leader in the 2024 SPARK Matrix™ Intelligent Business Process Management Suites (iBPMS) by QKS Group
-
Peabody Reports Results For Quarter Ended September 30, 2024
-
International Paper Announces Review of Strategic Options for Global Cellulose Fibers Business and Closure of Georgetown, S.C. Pulp and Paper Mill
-
Peabody Board Declares Dividend on Common Stock
-
CORRECTION: Aker Solutions ASA: Third-Quarter Results 2024
-
Daytona Unveils Agent-Agnostic Infrastructure for Sandboxing AI Coding Assistants
-
Xiamen Airlines wins APEX World-Class Airline award again, only Chinese airline honored
-
Barbara Bush Foundation for Family Literacy Launches National Celebration of Founder's Centennial
-
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
-
Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
-
Broadridge Launches New Digital Asset Information Platform to Help Financial Intermediaries Comply with Regulatory Guidelines
-
MCB Calls on Whitestone to Maximize Shareholder Value
-
CleanSpark Completes Acquisition of GRIID Infrastructure Inc.
-
Cortical.io Positioned as a Strong Contender in the 2024 SPARK Matrix™ Intelligent Document Processing (IDP) by QKS Group
-
AUXLY TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024
-
Southern Company reports third-quarter 2024 earnings
-
Tucows Announces Capital Efficiency Plan
-
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
International Paper Reports Third Quarter 2024 Results
-
Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
-
PureHealth Posts Net Profit of AED 1.4 Billion and Revenues Increase of 56% for 9 Months of 2024
-
Fannie Mae Reports Net Income of $4.0 Billion for Third Quarter 2024
-
Global Times: Creative souvenirs burst in creativity amid museum fever in China
-
Global Times: Exchanges, mutual understanding of civilizations indispensable to solving global problems
